Titan Pharmaceuticals Statistics
Total Valuation
TTNP has a market cap or net worth of $5.81 million. The enterprise value is -$320,614.
| Market Cap | 5.81M |
| Enterprise Value | -320,614 |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TTNP has 914,234 shares outstanding. The number of shares has increased by 13.58% in one year.
| Shares Outstanding | 914,234 |
| Shares Change (YoY) | +13.58% |
| Shares Change (QoQ) | +12.89% |
| Owned by Insiders (%) | 45.47% |
| Owned by Institutions (%) | 3.51% |
| Float | 700,056 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 66.73 |
| Forward PS | n/a |
| PB Ratio | 0.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.83, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.83 |
| Quick Ratio | 11.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -169.83 |
Financial Efficiency
Return on equity (ROE) is -99.90% and return on invested capital (ROIC) is -108.55%.
| Return on Equity (ROE) | -99.90% |
| Return on Assets (ROA) | -77.60% |
| Return on Capital (ROIC) | -108.55% |
| Revenue Per Employee | $21,750 |
| Profits Per Employee | -$1.24M |
| Employee Count | 4 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.14% in the last 52 weeks. The beta is 1.18, so TTNP's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -44.14% |
| 50-Day Moving Average | 6.24 |
| 200-Day Moving Average | 6.95 |
| Relative Strength Index (RSI) | 58.53 |
| Average Volume (20 Days) | 15,578 |
Short Selling Information
The latest short interest is 11,724, so 1.28% of the outstanding shares have been sold short.
| Short Interest | 11,724 |
| Short Previous Month | 7,841 |
| Short % of Shares Out | 1.28% |
| Short % of Float | 1.67% |
| Short Ratio (days to cover) | 1.16 |
Income Statement
In the last 12 months, TTNP had revenue of $87,000 and -$4.95 million in losses. Loss per share was -$6.45.
| Revenue | 87,000 |
| Gross Profit | 87,000 |
| Operating Income | -6.64M |
| Pretax Income | -4.95M |
| Net Income | -4.95M |
| EBITDA | -4.85M |
| EBIT | -4.93M |
| Loss Per Share | -$6.45 |
Balance Sheet
The company has $6.16 million in cash and $33,000 in debt, giving a net cash position of $6.13 million or $6.70 per share.
| Cash & Cash Equivalents | 6.16M |
| Total Debt | 33,000 |
| Net Cash | 6.13M |
| Net Cash Per Share | $6.70 |
| Equity (Book Value) | 6.09M |
| Book Value Per Share | 6.66 |
| Working Capital | 6.05M |
Cash Flow
In the last 12 months, operating cash flow was -$5.81 million and capital expenditures -$230,000, giving a free cash flow of -$6.04 million.
| Operating Cash Flow | -5.81M |
| Capital Expenditures | -230,000 |
| Free Cash Flow | -6.04M |
| FCF Per Share | -$7.08 |
Margins
Gross margin is 100.00%, with operating and profit margins of -7,635.63% and -5,694.25%.
| Gross Margin | 100.00% |
| Operating Margin | -7,635.63% |
| Pretax Margin | -5,694.25% |
| Profit Margin | -5,694.25% |
| EBITDA Margin | -5,579.31% |
| EBIT Margin | -5,660.92% |
| FCF Margin | -6,937.93% |
Dividends & Yields
TTNP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.58% |
| Shareholder Yield | -13.58% |
| Earnings Yield | -85.33% |
| FCF Yield | -103.97% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
TTNP has an Altman Z-Score of -77.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -77.87 |
| Piotroski F-Score | 1 |